PDCD1 and neoplasm: These observations support the hypothesis that kinetically, CTLA-4 acts as an early regulator of T cell function, while PD-1 may act more broadly to impair T cell activation, differentiation and survival as well as contribute to sustained T cell dysfunction within the tumor [59].